Posts
- Category: Articles (continued)
- Researchers discover system that reduces neurodegeneration in Huntington’s disease
- Researchers examines whether MRI can improve accuracy of Huntington’s diagnosis
- Researchers find chemical 'switches' for neurodegenerative diseases
- Researchers find controlling element of Huntington’s disease
- Researchers from Pasteur Institute Detail Findings in Neurons
- Researchers get a closer look at how the Huntington's gene works
- Researchers Identify New Links Between Genetic Abnormality and Brain Function in Huntington’s Disease
- Researchers Restore Neuron Function to Brains Damaged by Huntington's Disease
- Restoration of the striatal circuitry: from developmental aspects toward clinical applications
- Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting
- Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington’s Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate
- Rhenovia files patents for new treatment of Huntington’s disease based on its innovative biosimulation platform
- Rhenovia launches drug discovery for Huntington's disease, others
- Ricerca, cura e assistenza nella Malattia di Huntington: ultimi risultati raggiunti
- RNA Interference's Hot Partnership With Stem Cells
- Roche and Isis Pharmaceuticals Form Alliance for Huntington's Disease
- Roche gears up for pivotal Phase 3 Huntington’s disease gene-silencing clinical trial
- Roche ramps up Huntington’s disease clinical trial for early- to mid-stage stage patients, considers ways to expand research
- Roche: less frequent dosing for Phase 3 Huntington’s clinical trial, easing burden on patients
- Rottura della segnalazione cellulare porta alla neurodegenerazione
- Salute: la cisteina potrebbe portare benefici nella malattia di Huntington
- Sangamo BioSciences And Collaborators Highlight Widening Applications Of ZFP Therapeutics® In Presentations At Major Gene Therapy Meeting
- Sangamo BioSciences Announces First Presentation of Data from ZFP Therapeutic® for Huntington's Disease at 2012 Annual Meeting of Society for Neuroscience
- Sangamo BioSciences Announces Presentation Of First Demonstration Of In Vivo Efficacy Of Novel ZFP Therapeutic® For Huntington's Disease
- Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
- Sangamo Therapeutics Announces Nature Medicine Publication Detailing the Activity of Disease Allele-Selective Zinc Finger Proteins in Preclinical Models of Huntington’s Disease
- Sapienza. Trovata la proteina “salva-cervello”
- Scientist Converts Human Skin Cells Into Functional Brain Cells
- Scientists coax brain to regenerate cells lost in Huntington's disease
- Scientists deploy GM sheep in fight to treat Huntington’s disease
- Scientists find a way to target the protein behind Huntington’s disease
- Scientists hunt down origin of Huntington's disease in the brain
- Scientists identify early predictors for Huntington’s disease
- Scientists identify first gene in programmed axon degeneration
- Scientists move closer to treatment for Huntington's disease
- Scientists says tart fruit's antioxidants could reduce symptoms of Alzheimer's and Huntington's.
- Scientists tackle Huntington's disease by targeting mutant gene
- Scripps Florida Scientists Make Diseased Cells Synthesize Their Own Drug
- Scripps Florida Study Points to Drug Target for Huntington’s Disease
- Scripps Research Institute Scientists Identify First Potentially Effective Therapy for Human Prion Disease
- Seeing Beyond the Gene Second National Conference on Huntingtons Disease
- Selected by Chance: An Interview with Ralf Reilmann
- Sheep Help Scientists Fight Huntington’s Disease
- Sheep trials may find therapy for Huntington's
- Shining light on neurodegenerative pathway
- Siena Biotech – Comunicato AICH Roma Onlus
- Sigma-1 receptor Implicated in Cell Survival of Rare Neurodegenerative Diseases - Expanding the Opportunity for Application of ANAVEX PLUS in Rare Diseases
- SIGNAL: A new investigational approach to early treatment of Huntington’s disease
- Singulex Announces Collaboration with CHDI Foundation to Develop Biomarker Assays for Huntington’s Disease
- SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
Plugin by dagondesign.com
